14 unknown. 14 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Unknown 14 |
| Phase 1 | 3 | Unknown 3 |
Follow Hyperglycemia: new trials by email Literature Review of Hyperglycemia trials Research Report on Hyperglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level Taiwanese whole grain job's tear (red job's tear), White job's tear - Sarcopenia, Frailty | Phase 2 | Unknown | Taipei Veterans General Hospital, Taiwan | 80 | 2024-06-14 | 2024-07-16 |
| Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients Dapagliflozin 10mg Tab, lifestyle interventions - Prediabetic State, Impaired Fasting Glucose | Phase 2 | Unknown | Yangjin | 120 | 2023-12-20 | 2023-07-25 |
| Early Versus Conventional Cessation of Hydrocortisone in Septic Shock normal saline solution, Hydrocortisone and normal saline solution - Septic Shock, Adverse Event | Phase 2 | Unknown | Mahidol University | 160 | 2023-07-05 | 2024-04-05 |
| Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT Dorzagliatin, Placebo - Glucose Intolerance | Phase 1 / Phase 2 | Unknown | Chinese University of Hong Kong | 20 | 2022-08-01 | 2022-07-25 |
| Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose Metformin capsule 500 mg, Empagliflozin encapsulated tablet 10 mg, Pioglitazone encapsulated tablet 30 mg, Linagliptin encapsulated tablet 5 mg - Impaired Glucose Tolerance, Insulin Sensitivity | Phase 2 | Unknown | Oslo University Hospital | 64 | 2021-02-10 | 2021-04-08 |
| Magnesium Replacement and Hyperglycemia After Kidney Transplantation Mablet 360 mg, Placebo - Hypomagnesemia, Kidney Transplantation | Phase 1 / Phase 2 | Unknown | Oslo University Hospital | 40 | 2020-02-25 | 2021-09-28 |
| Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes melatonin, metformin, Placebo - PreDiabetes | Phase 2 | Unknown | University of Guadalajara | 42 | 2019-08-22 | 2019-09-26 |
| ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) ARA 290 - Diabetes Type 2, Impaired Glucose Tolerance | Phase 2 | Unknown | Claes-Göran Östenson | 24 | 2013-10-01 | 2015-09-03 |
| Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR LIM-0705, Placebo capsules - Impaired Glucose Tolerance, Insulin Resistance | Phase 2 | Unknown | Limerick BioPharma | 50 | 2011-05-01 | 2011-06-02 |
| Genetic Counseling and Lifestyle Change for Diabetes Prevention Diabetes Genetic Counseling, No genetic counseling - Pre-diabetes, Overweight | Phase 2 | Unknown | Massachusetts General Hospital | 90 | 2009-12-01 | 2011-07-20 |
| Effect of Sitagliptin in Impaired Glucose Tolerance Sitagliptin, Placebo - Impaired Glucose Tolerance | Phase 2 | Unknown | National Taiwan University Hospital | 60 | 2009-12-01 | 2010-03-22 |
| Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 Diabetics Autologous Adipose-derived Stem cells - Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | Unknown | Adistem Ltd | 34 | 2007-11-01 | 2008-07-01 |
| Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2 glucose control with computer generated recommendations - Critically Ill, Hyperglycemia | Phase 2 | Unknown | Intermountain Health Care, Inc. | 200 | 2007-09-01 | 2015-02-26 |
| Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1 glucose control with computer generated recommendations - Critically Ill, Hyperglycemia | Phase 2 | Unknown | Intermountain Health Care, Inc. | 200 | 2006-02-01 | 2015-02-26 |
Glucose Intolerance (8) · Insulin Resistance (5) · Diabetes Mellitus, Type 2 (3) · Critical Illness (2) · Diabetes Mellitus (2) · Prediabetic State (2) · Frailty (1) · Glucose Metabolism Disorders (1) · Hyperlipidemias (1) · Hypernatremia (1) · Inflammation (1) · Metabolic Syndrome (1) · Muscle Weakness (1) · Overweight (1)
Metabolic Diseases (14) · Nutritional and Metabolic Diseases (14) · Glucose Metabolism Disorders (13) · Hyperinsulinism (6) · Pathological Conditions, Signs and Symptoms (6) · Endocrine System Diseases (5) · Pathologic Processes (5) · Diabetes Mellitus (3) · Signs and Symptoms (3) · Disease Attributes (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Neuromuscular Manifestations (2) · Atrophy (1)
Metformin (2) · Biguanides (1) · Dorzagliatin (1) · Hydrocortisone (1) · Melatonin (1) · Saline Solution (1) · Sitagliptin Phosphate (1) · Thiazolidinediones (1) · dapagliflozin (1)
Intermountain Health Care, Inc. (2) · Oslo University Hospital (2) · Adistem Ltd (1) · Chinese University of Hong Kong (1) · Claes-Göran Östenson (1) · Limerick BioPharma (1) · Mahidol University (1) · Massachusetts General Hospital (1) · National Taiwan University Hospital (1) · Taipei Veterans General Hospital, Taiwan (1) · University of Guadalajara (1) · Yangjin (1)
United States (4) · Norway (2) · Taiwan (2) · China (1) · Mexico (1) · Philippines (1) · Sweden (1) · Thailand (1)
Alan H Morris, MD (2) · Anchun Hwang, Doctor (1) · Bill Paspaliaris, PhD (1) · Emeritta A Barrenechea, MD (1) · Florencio Q Lucero, MD (1) · Jin Yang, doctorate (1) · Lee-Ming Chuang, MD, PhD (1) · Letitia Lucero-Palma, MD (1) · Linda Morrow, MD (1) · Lizet Yadira Rosales-Rivera, PhD Science (1) · Richard W Grant, MD MPH (1) · Surat Tongyoo, Doctor (1)
PMID 22302620, PMID 22933432, PMID 38494571
R21DK084527 (1)